Care Ratings (CARERATING) | Financial Analysis & Statements
Care Ratings Ltd. Small-cap Financial Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
1.4B
Gross Profit
830.9M
60.93%
Operating Income
649.5M
47.63%
Net Income
572.1M
41.95%
EPS (Diluted)
₹18.81
Balance Sheet Metrics
Total Assets
9.6B
Total Liabilities
1.4B
Shareholders Equity
8.2B
Debt to Equity
0.17
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Care Ratings Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.0B | 3.3B | 2.8B | 2.5B | 2.4B |
| Cost of Goods Sold | 1.7B | 1.5B | 1.2B | 1.1B | 1.1B |
| Gross Profit | 2.3B | 1.8B | 1.5B | 1.3B | 1.3B |
| Gross Margin % | 56.8% | 54.8% | 55.5% | 54.6% | 54.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 178.9M | 154.0M | 118.1M | 108.5M | 94.4M |
| Other Operating Expenses | 344.0M | 350.5M | 235.9M | 252.4M | 155.9M |
| Total Operating Expenses | 523.0M | 504.5M | 354.0M | 360.9M | 250.2M |
| Operating Income | 1.4B | 1.0B | 946.4M | 724.9M | 925.7M |
| Operating Margin % | 35.9% | 31.0% | 33.9% | 29.4% | 38.7% |
| Non-Operating Items | |||||
| Interest Income | 455.3M | 425.5M | 350.5M | 247.7M | 156.1M |
| Interest Expense | 21.1M | 17.1M | 10.0M | 4.6M | 6.2M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 1.9B | 1.5B | 1.3B | 986.3M | 1.2B |
| Income Tax | 522.6M | 440.7M | 402.9M | 218.0M | 276.8M |
| Effective Tax Rate % | 27.2% | 30.1% | 32.0% | 22.1% | 23.3% |
| Net Income | 1.4B | 1.0B | 854.6M | 768.3M | 909.7M |
| Net Margin % | 34.8% | 30.9% | 30.6% | 31.1% | 38.0% |
| Key Metrics | |||||
| EBITDA | 2.0B | 1.6B | 1.4B | 1.1B | 1.2B |
| EPS (Basic) | ₹45.89 | ₹33.77 | ₹28.17 | ₹25.45 | ₹30.38 |
| EPS (Diluted) | ₹45.69 | ₹33.67 | ₹28.17 | ₹25.31 | ₹30.33 |
| Basic Shares Outstanding | 29903876 | 29769638 | 29655883 | 29510126 | 29461214 |
| Diluted Shares Outstanding | 29903876 | 29769638 | 29655883 | 29510126 | 29461214 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Care Ratings Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 488.2M | 382.9M | 494.2M | 176.3M | 120.9M |
| Short-term Investments | 6.0B | 5.9B | 5.2B | 5.0B | 4.8B |
| Accounts Receivable | 320.9M | 224.9M | 203.8M | 166.4M | 213.6M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 73.8M | 138.4M | 121.3M | 1.0K | 72.0K |
| Total Current Assets | 6.9B | 6.7B | 6.0B | 5.6B | 5.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.0B | 210.0M | 973.5M | 102.6M | 74.7M |
| Goodwill | 285.3M | 249.1M | 221.1M | 244.6M | 193.8M |
| Intangible Assets | 126.3M | 90.1M | 62.1M | 85.6M | 34.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 18.2M | -1.0K | 3.5M | -84.0K | 828.0K |
| Total Non-Current Assets | 2.7B | 1.7B | 1.7B | 1.6B | 1.3B |
| Total Assets | 9.6B | 8.4B | 7.7B | 7.3B | 6.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 151.4M | 133.2M | 102.7M | 51.3M | 37.7M |
| Short-term Debt | 32.7M | 24.1M | 22.0M | 32.7M | 27.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 450.9M | -1.0K | 218.2M | -2.0K | 113.1M |
| Total Current Liabilities | 978.0M | 786.8M | 578.1M | 512.3M | 528.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 204.9M | 171.5M | 152.8M | 56.4M | 44.8M |
| Deferred Tax Liabilities | 66.0M | 54.8M | 49.4M | 60.6M | 105.0M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 444.4M | 385.0M | 327.7M | 233.7M | 258.4M |
| Total Liabilities | 1.4B | 1.2B | 905.8M | 746.0M | 787.3M |
| Equity | |||||
| Common Stock | 299.3M | 298.5M | 297.0M | 296.5M | 294.6M |
| Retained Earnings | - | 3.6B | 3.3B | 3.0B | 2.7B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 8.2B | 7.2B | 6.8B | 6.5B | 5.9B |
| Key Metrics | |||||
| Total Debt | 237.7M | 195.5M | 174.8M | 89.1M | 72.3M |
| Working Capital | 5.9B | 6.0B | 5.4B | 5.1B | 4.9B |
Balance Sheet Composition
Care Ratings Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.9B | 1.5B | 1.3B | 986.3M | 1.2B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 18.8M | 27.1M | 4.8M | 65.3M | 35.7M |
| Working Capital Changes | 118.4M | 133.6M | 41.2M | 37.4M | 129.0M |
| Operating Cash Flow | 1.6B | 1.2B | 991.8M | 844.9M | 1.2B |
| Investing Activities | |||||
| Capital Expenditures | -147.4M | -91.7M | -114.8M | -187.6M | -42.2M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -950.0M | -3.9B | -1.5B | -2.4B | -2.0B |
| Investment Sales | 31.1M | 3.2B | 1.6B | 2.1B | 1.5B |
| Investing Cash Flow | -1.1B | -790.5M | -58.5M | -524.3M | -544.4M |
| Financing Activities | |||||
| Share Repurchases | - | 0 | -18.5M | 0 | - |
| Dividends Paid | -549.1M | -668.9M | -597.6M | -383.0M | -397.7M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -507.0M | -589.5M | -594.0M | -318.6M | -397.7M |
| Free Cash Flow | 1.1B | 817.1M | 707.4M | 490.2M | 816.8M |
| Net Change in Cash | 57.2M | -148.2M | 339.3M | 2.0M | 257.8M |
Cash Flow Trend
Care Ratings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
29.86
Forward P/E
24.59
Price to Book
5.56
Price to Sales
10.62
PEG Ratio
1.04
Profitability Ratios
Profit Margin
35.60%
Operating Margin
32.69%
Return on Equity
16.83%
Return on Assets
14.33%
Financial Health
Current Ratio
6.33
Debt to Equity
2.91
Beta
0.35
Per Share Data
EPS (TTM)
₹53.52
Book Value per Share
₹287.63
Revenue per Share
₹150.82
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CARERATING | 46.9B | 29.86 | 5.56 | 16.83% | 35.60% | 2.91 |
| BSE Limited | 1.4T | 65.54 | 22.34 | 28.98% | 50.73% | 0.00 |
| Multi Commodity | 710.5B | 111.91 | 22.74 | 29.72% | 51.72% | 0.02 |
| Crisil | 312.2B | 37.14 | 10.29 | 25.25% | 21.56% | 9.79 |
| Icra | 51.9B | 28.27 | 4.80 | 16.07% | 32.95% | 0.01 |
Financial data is updated regularly. All figures are in the company's reporting currency.




